Learn why Baxter chose to partner with Syngene for Stability studies, the business flow, governance mechanism and metrics that were implemented, which enabled a mutully successful collaboration.

Learn how Syngene developed and commercialized for its client, a complex palatable dosage form comprising three actives for use in companion animals.

Read how Syngene’s partnership with a leading Biotech company working in the field  of cancer therapy, grew from one small pilot project to over  100 FTEs today.